Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial oxidation of beta-hydroxybutyrate is a biochemical process where the ketone body beta-hydroxybutyrate (BHB) is transported into mitochondria and oxidized to acetoacetate by beta-hydroxybutyrate dehydrogenase. Acetoacetate is further metabolized to acetoacetyl-CoA and then to acetyl-CoA, feeding into the tricarboxylic acid (TCA) cycle to produce ATP, supporting cellular energy needs, particularly during periods of low glucose availability (fasting, prolonged exercise, ketogenic diets). This process is vital in organs such as the brain, heart, and kidney. In addition to serving as an energy substrate, BHB also acts as a signaling molecule influencing autophagy, mitochondrial biogenesis, oxidative stress response, inflammation, and epigenetic regulation through histone modifications[1][2][3][4][5].
For exogenous BHB: Serves as a substrate for mitochondrial oxidation, raising ATP via TCA cycle entry[1][5]. Modulates NAD+/NADH ratio, activating sirtuin signaling[1]. Indirect epigenetic modulation (histone beta-hydroxybutyrylation, HDAC inhibition)[4]. Anti-inflammatory effects via NLRP3 inflammasome inhibition[4].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial oxidation of beta-hydroxybutyrate.